Can Gene Therapy Prevent Blindness? What You Need to Know – Health Essentials from Cleveland Clinic (blog)
Health Essentials from Cleveland Clinic (blog) |
Can Gene Therapy Prevent Blindness? What You Need to Know
Health Essentials from Cleveland Clinic (blog) “We will see significant advances in gene transfer therapy, stem cell therapies and drug therapies for hereditary retinal diseases in the coming decades.” To prepare for these emerging therapies, Cleveland Clinic eye experts work with genetic … |
|
Research turns stem cells into skin grafts
Daily Mining Gazette Provided photo An MTU research project has developed a way to produce natural skin grafts from a person’s own stem cells. HOUGHTON — For burn victims and people with other injuries which cause damage to skin, skin grafts are an important part of … |
Investopedia |
Amgen, Immatics Launch Up-to-$1B+ Cancer Immunotherapy Alliance
Genetic Engineering & Biotechnology News Amgen will partner with Immatics Biotechnologies to develop next-generation, T-cell engaging bispecific immunotherapies targeting multiple cancers, through a collaboration the companies said today could generate more than $1 billion for Immatics. Amgen (AMGN), Immatics Biotechnologics To Collaborate On Novel Bispecific Cancer Immunotherapies DevelopmentStreetInsider.com Amgen, Immatics In Cancer Drug Partnership (AMGN)Investopedia Amgen Invests $30M In Immatics, Up To $1 Billion In Future PaymentssocalTech.com |
Next Big Future |
Interference: A CRISPR Patent Dispute Roadmap
Bio-IT World January 9, 2017 | Emmanuelle Charpentier and Jennifer Doudna have become world renowned for their discoveries and development involving CRISPR/Cas9, a gene-editing technology that has been called “one of the most important genetic inventions of … CRISPR could make designer babies and help with many diseases and moreNext Big Future |
|
TissueGene to Highlight Invossa™, the World’s First Cell-Mediated Gene Therapy for Degenerative Osteoarthritis, at …
Yahoo Finance Mr. Lee will introduce TissueGene’s Invossa™, the world’s first cell and gene therapy for degenerative arthritis. Invossa™ is a first-in-class osteoarthritis drug designed to conveniently and effectively treat osteoarthritis of the knee through a … |
|
TissueGene to Highlight Invossa™, the World’s First Cell-Mediated Gene Therapy for Degenerative
PR Newswire (press release) Mr. Lee will introduce TissueGene’s Invossa™, the world’s first cell and gene therapy for degenerative arthritis. Invossa™ is a first-in-class osteoarthritis drug designed to conveniently and effectively treat osteoarthritis of the knee through a … |
iTech Post |
Stem Cell Therapy: Miracle Cure Disovered For Girl With Cerebral Palsy
iTech Post FARMINGTON, CT – AUGUST 27: Senior postdoctoral fellow Xiaofang Wang pulls out frozen stem cells in a lab at the University of Connecticut`s (UConn) Stem Cell Institute at the UConn Health Center on August 27, 2010 in Farmington, Connecticut. UConn … Cell Banking Outsourcing Market Headed for Growth and Global Expansion by 2016 – 2022Satellite PR News (press release) |
